Perrigo’s Full Range Of Pseudoephedrine Stand-Ins Must Wait For Next Year
This article was originally published in The Tan Sheet
Executive Summary
Perrigo will not have a complete phenylephrine portfolio available to replace pseudoephedrine products until next year's cough/cold season, the company said during a fiscal 2006 first-quarter earnings call
You may also be interested in...
Replacing Pseudoephedrine Easier Said Than Done, OTC Firms Find
Reformulating pseudoephedrine products has posed a greater challenge than expected for a number of firms, as passage of a federal bill restricting sale of the ingredient looms
Replacing Pseudoephedrine Easier Said Than Done, OTC Firms Find
Reformulating pseudoephedrine products has posed a greater challenge than expected for a number of firms, as passage of a federal bill restricting sale of the ingredient looms
Replacing Pseudoephedrine Easier Said Than Done, OTC Firms Find
Reformulating pseudoephedrine products has posed a greater challenge than expected for a number of firms, as passage of a federal bill restricting sale of the ingredient looms